Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bartter Syndrome | 1 | 2017 | 11 | 0.72 | Why? |
| Cell Extracts | 1 | 2017 | 27 | 0.71 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 113 | 0.66 | Why? |
| Meningitis, Viral | 1 | 2017 | 97 | 0.62 | Why? |
| Cryptococcosis | 1 | 2017 | 97 | 0.62 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.61 | Why? |
| Pneumococcal Vaccines | 2 | 2018 | 571 | 0.60 | Why? |
| Pneumococcal Infections | 2 | 2018 | 562 | 0.58 | Why? |
| Respiratory Tract Infections | 7 | 2018 | 6817 | 0.57 | Why? |
| Respiratory Syncytial Virus Infections | 5 | 2018 | 1234 | 0.53 | Why? |
| Pulmonary Medicine | 1 | 2020 | 706 | 0.52 | Why? |
| Receptors, Leukotriene | 1 | 2012 | 13 | 0.50 | Why? |
| Encephalitis, Viral | 1 | 2017 | 355 | 0.49 | Why? |
| Leukotrienes | 1 | 2012 | 37 | 0.48 | Why? |
| Infant | 25 | 2020 | 30274 | 0.48 | Why? |
| Bronchiolitis Obliterans | 1 | 2012 | 86 | 0.48 | Why? |
| Food Hypersensitivity | 2 | 2017 | 397 | 0.45 | Why? |
| Palatine Tonsil | 1 | 2012 | 127 | 0.44 | Why? |
| DNA Viruses | 1 | 2013 | 184 | 0.44 | Why? |
| Pneumonia | 3 | 2021 | 5652 | 0.43 | Why? |
| Community-Acquired Infections | 3 | 2019 | 2328 | 0.43 | Why? |
| Child, Preschool | 24 | 2020 | 36283 | 0.43 | Why? |
| Microbiota | 2 | 2018 | 1240 | 0.41 | Why? |
| Coronavirus OC43, Human | 1 | 2018 | 1157 | 0.41 | Why? |
| Child | 30 | 2021 | 70012 | 0.40 | Why? |
| Rhinitis, Allergic | 1 | 2017 | 704 | 0.39 | Why? |
| Dermatitis, Atopic | 1 | 2017 | 714 | 0.37 | Why? |
| Sleep Apnea Syndromes | 1 | 2012 | 282 | 0.37 | Why? |
| Nasopharynx | 3 | 2018 | 10224 | 0.35 | Why? |
| Adjuvants, Immunologic | 1 | 2017 | 1709 | 0.35 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.34 | Why? |
| Mycoplasma pneumoniae | 2 | 2019 | 233 | 0.33 | Why? |
| Anti-Infective Agents | 2 | 2019 | 1766 | 0.32 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.31 | Why? |
| China | 20 | 2021 | 50654 | 0.31 | Why? |
| Pneumonia, Mycoplasma | 2 | 2019 | 292 | 0.30 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.29 | Why? |
| Respiratory Syncytial Virus, Human | 4 | 2018 | 846 | 0.28 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.26 | Why? |
| Respiratory Tract Diseases | 1 | 2011 | 1061 | 0.25 | Why? |
| Parainfluenza Virus 1, Human | 2 | 2013 | 71 | 0.25 | Why? |
| Respiratory Syncytial Viruses | 2 | 2017 | 612 | 0.24 | Why? |
| Parvoviridae Infections | 2 | 2013 | 222 | 0.21 | Why? |
| RNA, Ribosomal, 23S | 1 | 2019 | 25 | 0.21 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.20 | Why? |
| NADPH Oxidases | 1 | 2019 | 80 | 0.19 | Why? |
| Granulomatous Disease, Chronic | 1 | 2019 | 60 | 0.19 | Why? |
| Bordetella pertussis | 1 | 2019 | 117 | 0.18 | Why? |
| Hepatomegaly | 1 | 2017 | 34 | 0.18 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.17 | Why? |
| Parainfluenza Virus 3, Human | 1 | 2017 | 67 | 0.17 | Why? |
| Vaccination | 2 | 2020 | 19050 | 0.17 | Why? |
| Rubella virus | 1 | 2017 | 46 | 0.17 | Why? |
| Infant Food | 1 | 2017 | 39 | 0.17 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.17 | Why? |
| Wiskott-Aldrich Syndrome | 1 | 2017 | 41 | 0.17 | Why? |
| Encephalitis Virus, Japanese | 1 | 2017 | 63 | 0.17 | Why? |
| Otitis Media | 1 | 2018 | 106 | 0.17 | Why? |
| Child, Hospitalized | 3 | 2019 | 556 | 0.16 | Why? |
| Respiratory Hypersensitivity | 1 | 2018 | 103 | 0.16 | Why? |
| Encephalitis Viruses, Tick-Borne | 1 | 2017 | 100 | 0.16 | Why? |
| Hydrocephalus | 1 | 2017 | 139 | 0.16 | Why? |
| Meningitis | 1 | 2018 | 163 | 0.16 | Why? |
| Antigens, Fungal | 1 | 2017 | 106 | 0.16 | Why? |
| Whooping Cough | 1 | 2019 | 201 | 0.16 | Why? |
| Acute Disease | 3 | 2015 | 6029 | 0.16 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.15 | Why? |
| Lung Diseases, Fungal | 1 | 2017 | 167 | 0.15 | Why? |
| Beijing | 2 | 2018 | 912 | 0.15 | Why? |
| Skin Tests | 1 | 2017 | 229 | 0.15 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.15 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.15 | Why? |
| Respiratory Sounds | 1 | 2018 | 294 | 0.15 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.14 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.14 | Why? |
| Humans | 38 | 2021 | 930598 | 0.13 | Why? |
| Allergy and Immunology | 1 | 2017 | 240 | 0.13 | Why? |
| Viral Fusion Proteins | 1 | 2018 | 399 | 0.13 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.13 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.13 | Why? |
| Female | 24 | 2020 | 380317 | 0.13 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.13 | Why? |
| Enterovirus | 1 | 2017 | 402 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.13 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.12 | Why? |
| Male | 23 | 2020 | 367725 | 0.12 | Why? |
| Drug Utilization | 1 | 2018 | 619 | 0.12 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Asthma | 3 | 2018 | 4383 | 0.12 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.11 | Why? |
| Metagenomics | 1 | 2017 | 823 | 0.11 | Why? |
| Respirovirus Infections | 1 | 2011 | 90 | 0.11 | Why? |
| Human bocavirus | 1 | 2011 | 142 | 0.11 | Why? |
| Cysteine | 1 | 2012 | 238 | 0.11 | Why? |
| Recurrence | 2 | 2018 | 3675 | 0.11 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.11 | Why? |
| Polysomnography | 1 | 2012 | 296 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Models, Statistical | 2 | 2018 | 5312 | 0.10 | Why? |
| Pneumonia, Bacterial | 1 | 2017 | 843 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.10 | Why? |
| Oropharynx | 1 | 2018 | 1581 | 0.10 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.10 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.10 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.10 | Why? |
| Respiratory Mucosa | 1 | 2018 | 1522 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.09 | Why? |
| Adolescent | 10 | 2020 | 86841 | 0.09 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.09 | Why? |
| Pediatrics | 2 | 2020 | 2969 | 0.09 | Why? |
| Prevalence | 6 | 2019 | 25773 | 0.09 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.08 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.08 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.08 | Why? |
| Hypersensitivity | 1 | 2017 | 1137 | 0.08 | Why? |
| Cough | 2 | 2020 | 4891 | 0.08 | Why? |
| Rhinovirus | 1 | 2013 | 979 | 0.08 | Why? |
| Allergens | 2 | 2018 | 728 | 0.08 | Why? |
| Headache | 1 | 2017 | 2257 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Fever | 3 | 2020 | 7795 | 0.07 | Why? |
| DNA, Bacterial | 2 | 2019 | 835 | 0.07 | Why? |
| Respiratory System | 1 | 2017 | 3213 | 0.07 | Why? |
| Outpatients | 2 | 2018 | 3417 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.07 | Why? |
| Antibody Formation | 1 | 2017 | 4038 | 0.07 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.07 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.06 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.06 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2020 | 12361 | 0.06 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Lung | 3 | 2021 | 31049 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Mutation | 2 | 2019 | 12376 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Radiography, Thoracic | 1 | 2017 | 5486 | 0.05 | Why? |
| Infant, Newborn | 5 | 2019 | 23105 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11367 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Gene Expression Regulation | 1 | 2012 | 4020 | 0.05 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.05 | Why? |
| Serotyping | 1 | 2018 | 154 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Hospitalization | 3 | 2018 | 54280 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.04 | Why? |
| Mali | 1 | 2017 | 181 | 0.04 | Why? |
| Haiti | 1 | 2017 | 175 | 0.04 | Why? |
| Coinfection | 2 | 2018 | 6820 | 0.04 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.04 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.04 | Why? |
| Point Mutation | 1 | 2019 | 481 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.04 | Why? |
| Macrolides | 1 | 2019 | 369 | 0.04 | Why? |
| Genetic Testing | 1 | 2019 | 395 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.03 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 552 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 13720 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Desensitization, Immunologic | 1 | 2017 | 574 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.03 | Why? |
| Pharynx | 1 | 2019 | 1544 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Developing Countries | 2 | 2017 | 4283 | 0.03 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.03 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| SARS Virus | 2 | 2003 | 13021 | 0.02 | Why? |
| Orthomyxoviridae | 1 | 2018 | 1168 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2018 | 2262 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Azithromycin | 1 | 2019 | 3943 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2003 | 51949 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Radiography | 1 | 2003 | 1576 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2003 | 7220 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
| Adult | 1 | 2018 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2018 | 270681 | 0.00 | Why? |